Ghisallo Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-100,000
Closed -$1.85M 106
2022
Q4
$1.85M Hold
100,000
0.33% 71
2022
Q3
$2.7M Buy
+100,000
New +$2.7M 0.36% 99